Xian-Janssen Pharmaceutical Ltd. clinical trials

A country office of Johnson & Johnson

The registry lists 36 studies whose lead sponsor is Xian-Janssen Pharmaceutical Ltd.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.

Studies

Recruiting first, then most recently updated. Showing 36 of 36. All Johnson & Johnson studies →

• A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)RecruitingNCT07310095Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Real-World Study of Guselkumab in Chinese Participants With Ulcerative ColitisRecruitingNCT07302360

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of HemorrhoidsCompletedNCT01881282Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in ChinaCompletedNCT06082986

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional DyspepsiaCompletedNCT03617016Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese ParticipantsCompletedNCT03053024

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne TabletsCompletedNCT03196531Phase 1

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyTerminatedNCT02895529Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or LeiomyosarcomaCompletedNCT01692678Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy ParticipantsWithdrawnNCT03220867Phase 1

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety SymptomsCompletedNCT01814098Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic ConstipationCompletedNCT02228616Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne TabletsCompletedNCT03151720Phase 1

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety SymptomCompletedNCT01870843Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic SyndromeCompletedNCT01751867Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With SchizophreniaCompletedNCT01947803Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral AntipsychoticsCompletedNCT01685931Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and FlatulenceCompletedNCT02340481Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTerminatedNCT01840943Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative ColitisCompletedNCT01551290Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) ParticipantsCompletedNCT01933880Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT01177800Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With CancerCompletedNCT01824524Phase 1

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Observational Study of Chinese Multiple Myeloma Patients Treated With VelcadeCompletedNCT01675245

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of SchizophreniaTerminatedNCT01894984

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart FailureCompletedNCT00813202Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCompletedNCT01814085Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid ArthritisCompletedNCT00896168Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back PainCompletedNCT01843660Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy VolunteersCompletedNCT01928316Phase 1

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With SchizophreniaCompletedNCT01541371Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With SchizophreniaCompletedNCT00604279Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal InfectionsCompletedNCT01823289Phase 4

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of SchizophreniaCompletedNCT00350467Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's DiseaseCompletedNCT00645190Phase 3

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.

• A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy VolunteersCompletedNCT00645554Phase 1

  Sponsor listed in the registry: Xian-Janssen Pharmaceutical Ltd.